Group 1: Earnings Performance - Nu Skin Enterprises reported quarterly earnings of 0.38pershare,exceedingtheZacksConsensusEstimateof0.22 per share, and showing a slight increase from 0.37pershareayearago[1]−Theearningssurpriseforthequarterwas72.730.17 per share against an expectation of 0.20,resultinginasurpriseof−15445.55 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.01%, but down from 488.64millionyear−over−year[3]−NuSkinhastoppedconsensusrevenueestimatestwotimesoverthelastfourquarters[3]Group3:StockPerformanceandOutlook−NuSkinshareshavedeclinedapproximately8.30.27 on revenues of 433.9million,andforthecurrentfiscalyear,itis0.76 on revenues of $1.8 billion [8] - The Zacks Industry Rank indicates that the Cosmetics industry is currently in the bottom 32% of over 250 Zacks industries, suggesting potential underperformance compared to higher-ranked industries [9] Group 4: Estimate Revisions and Ratings - Ahead of the earnings release, the estimate revisions trend for Nu Skin was unfavorable, resulting in a Zacks Rank 5 (Strong Sell) for the stock, indicating expected underperformance in the near future [7] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6]